Healthcare Equipment and Supplies
Company Overview of Data Sciences International, Inc.
Data Sciences International, Inc., a biomedical research company, designs and manufactures implantable telemetry devices for physiologic monitoring. The company provides implantable telemetry, external telemetry, software, hardwired amplification, respiratory products, glucose monitoring products, and infusion pumps. Its products are used in neuroscience, cardiovascular, respiratory, electrophysiology, chemical and biological defense, infusion, integrated pharmacology, and unique applications. The company also offers scientific services, such as surgical, data analysis, and validation assistance. It serves pharmaceuticals, academia, biological and chemical defense, medical device, and govern...
119 14th Street NW
St. Paul, MN 55112
Founded in 1984
Key Executives for Data Sciences International, Inc.
Compensation as of Fiscal Year 2014.
Data Sciences International, Inc. Key Developments
Data Sciences International, Inc. Launches Telemetry Implant for Continuous Real-Time Glucose Measurement
May 21 14
Data Sciences International (DSI) has introduced the first-ever glucose telemetry implant for obtaining continuous, real-time measurements of blood glucose in laboratory animals. Because the sensor is placed directly into the bloodstream, researchers are now able to detect instantaneous changes in blood glucose, body temperature, and activity for 28 days or longer while reducing animal stress and measurement variability commonly associated with the use of glucose test strips. The Centers for Disease Control and Prevention (CDC) estimates that diabetes affects 26 million people in the U.S. alone, or 8.3% of the population. Diabetes is a major cause of heart disease, stroke, kidney failure, lower-limb amputations, and blindness. The National Institutes of Health (NIH) is providing an estimated $1 billion in funding for diabetes research in 2014. In addition, with nearly every major pharmaceutical company engaged in the development of new treatments for diabetes and metabolic disease, demand for better research instrumentation has also increased.
Bioanalytical Systems Inc. Announces Pivotal Study with Data Sciences International, Inc
Dec 7 12
Bioanalytical Systems Inc. announced that it is collaborating with Data Sciences International, Inc. to conduct study combining Bioanalytical Systems Inc.'s Culex-L automated sampling system with Data Sciences International, Inc.'s PhysioTel Digital. In this pivotal study, Bioanalytical Systems Inc.'s Culex-L automated in vivo sampling system will simultaneously collect biological samples at pre-programmed intervals while Data Sciences International, Inc. telemetry devices will collect heart rate, blood pressure and other cardiovascular information.
Similar Private Companies By Industry
Recent Private Companies Transactions